Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
EV-to-EBITDA is calculated as enterprise value divided by its EBITDA. As of today, Jinxin Fertility Group's enterprise value is $998.4 Mil.
Jinxin Fertility Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-126.6 Mil. Therefore, Jinxin Fertility Group's EV-to-EBITDA for today is -7.88.
The historical rank and industry rank for Jinxin Fertility Group's EV-to-EBITDA or its related term are showing as below:
JXFGF'
s EV-to-EBITDA Range Over the Past 10 Years
Min: -14.59 Med: 23.32 Max: 91.1
Current: -7.87
During the past 10 years, the highest EV-to-EBITDA of Jinxin Fertility Group was 91.10. The lowest was -14.59. And the median was 23.32.
JXFGF's EV-to-EBITDA is ranked worse than 100% of 513
companies
in the Healthcare Providers & Services industry
Industry Median: 10.81
vs JXFGF: -7.87
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio to determine the fair market value of a company.
Jinxin Fertility Group (OTCPK:JXFGF) EV-to-EBITDA Explanation
EV-to-EBITDA is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the PE Ratio (TTM) to determine the fair market value of a company.
Jinxin Fertility Group's PE Ratio (TTM) for today is calculated as:
Jinxin Fertility Group's share price for today is $0.29.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jinxin Fertility Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Dec. 2025 was $-0.050.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Study has found that the companies with the lowest EV-to-EBITDA outperforms companies measured as cheap by other ratios such as PE Ratio (TTM).
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Jinxin Fertility Group's EV-to-EBITDA, along with its competitors' market caps and EV-to-EBITDA data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Jinxin Fertility Group EV-to-EBITDA vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Jinxin Fertility Group's EV-to-EBITDA distribution charts can be found below:
* The bar in red indicates where Jinxin Fertility Group's EV-to-EBITDA falls into.
Jinxin Fertility Group's current Enterprise Value is $998.4 Mil.
For company reported semi-annually, GuruFocus uses latest annual data as the TTM data. Jinxin Fertility Group's EBITDA for the trailing twelve months (TTM) ended in Dec. 2025 was $-126.6 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Jinxin Fertility Group (JXFGF) has a EV-to-EBITDA of -7.88 as of Aug. 12, 2026. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Jinxin Fertility Group. According to the industry distribution chart, Jinxin Fertility Group ranks #999999 out of 513 companies in the Healthcare Providers & Services industry.
Is Jinxin Fertility Group's EV-to-EBITDA too high?
Jinxin Fertility Group's current EV-to-EBITDA is -7.88. Based on the distribution chart, Jinxin Fertility Group ranks #999999 out of 513 companies in the Healthcare Providers & Services industry, which is in the bottom quartile relative to peers. Overall, Jinxin Fertility Group has a GF Score™ of 81/100, reflecting its overall financial health beyond just this single metric.
How does Jinxin Fertility Group's EV-to-EBITDA compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Jinxin Fertility Group ranks #999999 out of 513 companies for EV-to-EBITDA. This places Jinxin Fertility Group in the lower half of its industry. The industry median EV-to-EBITDA is 10.81. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBITDA for a Healthcare Providers & Services company?
The median EV-to-EBITDA among Healthcare Providers & Services companies is 10.81, based on 513 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBITDA significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBITDA should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBITDA mean?
A high EV-to-EBITDA can signal that a stock is expensive relative to its fundamentals. EV to EBITDA ratio is the company's enterprise value divided by earnings before interest, taxes, depreciation and amortization. View historical data on Jinxin Fertility Group. For the Healthcare Providers & Services industry, the median EV-to-EBITDA is 10.81 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Jinxin Fertility Group's current EV-to-EBITDA is -7.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Jinxin Fertility Group stock overvalued right now?
Jinxin Fertility Group (JXFGF) has a current EV-to-EBITDA of -7.88. The stock's GF Value™ is $0.51, compared to a current price of $0.29 — trading 43.1% below its estimated fair value. The current EV-to-EBITDA is -7.88. Jinxin Fertility Group's overall GF Score™ is 81/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBITDA calculated?
EV-to-EBITDA is calculated from a company's financial statements. For Jinxin Fertility Group (JXFGF), the current EV-to-EBITDA is -7.88 as of Aug. 12, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Jinxin Fertility Group (JXFGF) Overvalued in 2026?
Based on GuruFocus' analysis, Jinxin Fertility Group stock appears to be undervalued.
The current stock price of $0.29 is trading 43.1% below its estimated GF Value™ of $0.51.
Key valuation signals for JXFGF:
EV-to-EBITDA: -7.88
GF Value™: $0.51 vs. price of $0.29 (43.1% below fair value)
No single metric tells the full story. See the JXFGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Jinxin Fertility Group Ltd is an investment holding company. Along with its subsidiaries, it is engaged in providing IVF services in both China and the United States. The firm, through its subsidiary, is engaged in Assisted reproductive services, management services, ambulatory surgery centre facilities services, obstetrics, gynecology & pediatrics medical services, sales of medical consumables and equipment. and ancillary medical services. Geographically, the company generates a majority of its revenue from Greater China, with a small portion of revenue generated from Overseas Business.
81GF Score
Get the complete analysis for JXFGF
EV-to-EBITDA is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
JXFGF has been successfully added to your 
